← Eichor
Condition: Brain Neoplasms Primary Malignant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Brain Neoplasms Primary Malignant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
Phase 1/Phase 2 · 3 location(s) · Institute of Cancer Research, United Kingdom · NCT06630260SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT052541975G-PEARL: Paxalisib in Malignant Brain Tumours
Phase 1/Phase 2 · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT07391215Intravital Microscopy in Human Solid Tumors
NA · 1 location(s) · Mayo Clinic · NCT03823144Experiences and Needs of Patients With a High-grade Glioma and Their Caregivers
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT01638130Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT04988009An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
Phase 1/Phase 2 · 3 location(s) · Beijing Tide Pharmaceutical Co., Ltd · NCT07371663Non-invasive Glioma Characterization Through Molecular Imaging
NA · 1 location(s) · University of Miami · NCT03684109Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
Phase N/A · 1 location(s) · N.N. Petrov National Medical Research Center of Oncology · NCT05539677FearLess in NeuroOncology
NA · 1 location(s) · Virginia Commonwealth University · NCT06989086The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06118723Cancer Genetic Testing in Ethnic Populations
NA · 2 location(s) · Mayo Clinic · NCT04475640Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors
Phase N/A · 1 location(s) · Pietro Mortini, MD, Prof. · NCT05831631Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Phase 1/Phase 2 · 4 location(s) · Nationwide Children's Hospital · NCT05278208HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Phase 1 · 3 location(s) · M.D. Anderson Cancer Center · NCT03911388CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Phase 1/Phase 2 · 35 location(s) · Children's Oncology Group · NCT04870944A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma
Phase N/A · 8 location(s) · National Health Research Institutes, Taiwan · NCT05622409Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and
Phase 1 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT069144795G-EMERALD: Amivantamab in Malignant Brain Tumours
Phase 1 · 2 location(s) · Institute of Cancer Research, United Kingdom · NCT06632236
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.